Skip to main content
. 2022 Sep 13;82(2):212–216. doi: 10.1136/ard-2022-222731

Figure 2.

Figure 2

Kaplan-Meier estimate of time to first flare (weeks) through 104 weeks for patients who were randomised to placebo (IXE withdrawal) or continuous IXE. ‡P<0.001 versus placebo (IXE withdrawal). IXE, ixekizumab; N, number of patients; PBO, placebo; Q2W, every 2 weeks; Q4W, every 4 weeks.